Newleos Therapeutics, Inc.
Clinical trials sponsored by Newleos Therapeutics, Inc., explained in plain language.
-
New pill aims to curb alcohol cravings in heavy drinkers
Disease control Recruiting nowThis early-stage study tests an experimental drug called NTX-2001 in 50 adults with Alcohol Use Disorder. Participants take the drug or a placebo daily for two weeks to see if it reduces alcohol consumption and is safe. The goal is to find a new treatment option for people who st…
Phase: PHASE1 • Sponsor: Newleos Therapeutics, Inc. • Aim: Disease control
Last updated Jun 08, 2026 13:13 UTC
-
New pill aims to calm social anxiety without lifelong meds
Symptom relief Recruiting nowThis study tests a new drug, NTX-1472, in 100 adults with social anxiety disorder. Participants take either the drug or a placebo daily for 8 weeks, with 6 clinic visits over 14 weeks. The goal is to see if the drug safely reduces anxiety and avoidance in social situations.
Phase: PHASE2 • Sponsor: Newleos Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 22, 2026 12:09 UTC